Centor vs McIsaac Score: Strep Throat Testing Guide | Hippo Education

It’s 9 a.m. in urgent care, and your next patient is here for a sore throat. They want a rapid strep test and antibiotics. But we all know that most sore throats are viral, and antibiotics won’t help. That’s exactly why clinical decision tools, such as the Centor and McIsaac criteria, matter. They guide testing decisions, help us avoid unnecessary antibiotics, and keep care efficient on a busy shift.

Let’s break it down.

Centor and McIsaac: Not Perfect, But Practical

Both the Centor score for diagnosing strep pharyngitis and its age‑adjusted cousin, the McIsaac score, help estimate the likelihood of Group A Streptococcus (GAS) as the cause of pharyngitis. Classic Centor criteria include:

• Fever
  
  
• Absence of cough
  
  
• Tonsillar exudate/swelling
  
  
• Tender anterior cervical lymph nodes
  
  

The McIsaac score takes it a step further, adjusting for age: +1 for kids 3–14 →where strep is more common), 0 for ages 15–44, and –1 for adults 45 and older →Why? Because Group A Strep is rare under 3 and less likely over 45.

Here’s how the McIsaac scoring plays out:

• Score 0–1 → no strep testing needed
  
  
• Score 2–3 → test with a rapid strep
  
  
• Score ≥4 → empiric treatment reasonable, though testing is still ideal
  
  

But are the scores equivalent?

They are! A large meta‑analysis comparing Centor and McIsaac scores in primary care found they perform similarly. The summary receiver‑operating characteristic (ROC) areas were close for both (about 0.69 for Centor and 0.71 for McIsaac) and not statistically different, suggesting neither is clearly superior. Both tools were only fair at identifying true strep cases, and neither was accurate enough on its own to “rule in” infection. However, a score of ≤0 on either score may be useful to rule out GAS and avoid testing altogether.

Why This Matters for Testing Decisions

In urgent care, reflexively swabbing every sore throat is inefficient and can drive unnecessary antibiotic use. The BJGP meta‑analysis highlighted that these scores alone wouldn’t prevent inappropriate antibiotic prescriptions if used rigidly, and other point‑of‑care diagnostics might be needed to improve accuracy.

Here’s how this plays out on shift:

• Low score (0–1): Skip strep testing. Symptoms are more likely viral. Reassure, treat symptoms, and educate about when to return.
  
  
• Moderate score (2–3): Perform a rapid strep test and use results to guide management.
  
  
• High score (≥4): Testing is still preferred, but many clinicians will consider empiric antibiotics if testing isn’t immediately available and the clinical picture supports it.
  
  

This approach aligns with rational antibiotic stewardship. Treating only confirmed infections (or high‑risk clinical scenarios) reduces antibiotic exposure when they’re unlikely to help.

Because, let’s face it, overprescribing for viral pharyngitis isn’t just bad medicine, it’s a public health problem. Group A Strep accounts for only a fraction of sore throats, and many positives may reflect colonization rather than active infection. So testing wisely means treating only when it’s necessary.

Bottom line? If your patient’s score is low, skip the swab. If it’s intermediate, test. And if it’s high, test or treat depending on your clinical judgment and the patient’s risk profile.

Putting It Into Practice

Here’s a quick urgent care workflow for a sore throat:

1. Perform history and physical exam.
   
   
2. Apply Centor or McIsaac score.
   
   
3. Decide on testing based on score.
   
   
4. Use rapid strep results (or clinical judgment for high scores) to guide antibiotic decisions.
   
   
5. Educate patients about viral causes, symptomatic care, and red flags.
   
   

By leaning into evidence‑based tools like Centor and McIsaac—and understanding their strengths and limits — you’ll make smarter pharyngitis management decisions, protect patients from unnecessary antibiotics, and keep your urgent care flow moving.